Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Merck
QuintilesIMS
US Department of Justice
Cantor Fitzgerald

Generated: August 25, 2019

DrugPatentWatch Database Preview

Claims for Patent: 7,927,815

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,927,815
Title:Protein purification method
Abstract: A method for removing contaminant DNA in a sample containing a physiologically active protein, which comprises the following steps: 1) converting the sample containing a physiologically active protein into a neutral aqueous solution of low conductivity; and 2) removing the resulting particles.
Inventor(s): Takeda; Kozo (Tokyo, JP), Ochi; Norimichi (Tokyo, JP)
Assignee: Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP)
Application Number:12/018,688
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,927,815
Patent Claims:1. A method for removing contaminant DNA in a sample containing a physiologically active protein, which comprises the following steps: 1) converting the sample containing a physiologically active protein into an acidic aqueous solution of low conductivity of 300 mS/m or less and having a molarity of 100 mM or less at pH of 1.5 to 3.9; 2) adjusting the pH of the resulting sample from step (1) to pH of 4 to 8 to form particles, wherein the molarity of the adjusted sample is 100 mM or less; and 3) removing the particles thereby to remove contaminant DNA in the sample.

2. The method according to claim 1, wherein the acidic aqueous solution of low conductivity has a molarity of 50 mM or less.

3. The method according to claim 1, wherein the acidic aqueous solution of low conductivity has an ionic strength of 0.2 or less.

4. The method according to claim 1, wherein the acidic aqueous solution is selected from the group consisting of aqueous solutions of hydrochloric acid, citric acid and acetic acid.

5. The method according to claim 1, wherein the contaminant DNA is present at a DNA concentration of 22.5 pg/ml or less in the treated sample containing a physiologically active protein.

6. The method according to claim 1, wherein the physiologically active protein is an antibody.

7. The method according to claim 6, wherein the antibody is a humanized monoclonal antibody.

8. The method according to claim 7, wherein the antibody is a humanized anti-IL-6 receptor antibody.

9. The method according to claim 7, wherein the antibody is a humanized anti-HM1.24 antigen monoclonal antibody.

10. The method according to claim 7, wherein the antibody is a humanized anti-parathyroid hormone-related peptide antibody (anti-PTHrP antibody).

11. The method according to claim 7, wherein the antibody is a humanized anti-tissue factor antibody.

12. The method according to claim 1, wherein the particles are removed by filtration through a filter.

13. A method for removing contaminant DNA in a sample containing a physiologically active protein, which comprises: 1) converting the sample containing a physiologically active protein into an acidic aqueous solution of low conductivity of 300 mS/m or less and having a molarity of 100 mM or less at pH of 1.5 to 3.9; 2) neutralizing the pH of the resulting sample from step (1) by addition of a buffer to raise the pH to a neutral level to form particles, wherein the molarity of the neutralized sample is 100 mM or less; and 3) filtering the resulting sample from step (2) to remove particles containing contaminant DNA.

Summary for Patent:   Try a Free Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2001-067111Mar 9, 2001

Details for Patent 7,927,815

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2021-03-09 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2021-03-09 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2021-03-09 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Try a Free Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2021-03-09 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Colorcon
Covington
Deloitte
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.